Skip to main content
H.R. 5381 116th Congress House

International Pharmaceutical Transparency Act of 2019

Official title: To amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug to list the country of origin of each of the drug's active ingredients.

Introduced: December 10, 2019 Introduced by: Scott DesJarlais Republican · Tennessee See on congress.gov
Health Consumer affairsDrug safety, medical device, and laboratory regulationPrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 11, 2019
Referred to the Subcommittee on Health.
Dec 10, 2019
Referred to the House Committee on Energy and Commerce.
Dec 10, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action December 11, 2019

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

International Pharmaceutical Transparency Act of 2019

This bill prohibits the sale of a drug if its label fails to list the country of origin of each of the drug's active ingredients.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5381: International Pharmaceutical Transparency Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-5381/
MLA
"H.R. 5381: International Pharmaceutical Transparency Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-5381/.
Bluebook (legal)
H.R. 5381, 116th Cong. (2026), https://openamerica.io/bill/116-HR-5381/.
Markdown link
[H.R. 5381: International Pharmaceutical Transparency Act of 2019](https://openamerica.io/bill/116-HR-5381/)
Report a problem